Sphere Fluidics and Geneva Biotech receive Eurostars genome editing grant
€1.6 million grant will support ‘precise docking of very large DNA cargoes in genomes’ project Cambridge, UK, and Geneva, Switzerland, 27 November 2017: Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, and Geneva Biotech, an EMBL spin-out developing world-class viral and non-viral DNA delivery systems, have received a... Read more